ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 163 filers reported holding ANIKA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $621,339 | -29.9% | 22,970 | +7.4% | 0.00% | – |
| Q3 2021 | $886,000 | +281.9% | 21,390 | +317.2% | 0.00% | – |
| Q2 2021 | $232,000 | +40.6% | 5,127 | +26.1% | 0.00% | – |
| Q1 2021 | $165,000 | -2.4% | 4,067 | -0.4% | 0.00% | – |
| Q4 2020 | $169,000 | +196.5% | 4,082 | +156.4% | 0.00% | – |
| Q3 2020 | $57,000 | +3.6% | 1,592 | +0.9% | 0.00% | – |
| Q2 2020 | $55,000 | +358.3% | 1,578 | +312.0% | 0.00% | – |
| Q1 2020 | $12,000 | -87.1% | 383 | -78.7% | 0.00% | – |
| Q4 2019 | $93,000 | +24.0% | 1,801 | +31.3% | 0.00% | – |
| Q3 2019 | $75,000 | +33.9% | 1,372 | -0.1% | 0.00% | – |
| Q2 2019 | $56,000 | -95.9% | 1,373 | -97.0% | 0.00% | -100.0% |
| Q1 2019 | $1,367,000 | +2937.8% | 45,200 | +3371.6% | 0.00% | – |
| Q4 2018 | $45,000 | -23.7% | 1,302 | -8.2% | 0.00% | – |
| Q3 2018 | $59,000 | -28.0% | 1,418 | -45.1% | 0.00% | – |
| Q2 2018 | $82,000 | -36.9% | 2,582 | -1.5% | 0.00% | – |
| Q1 2018 | $130,000 | -13.3% | 2,620 | -5.8% | 0.00% | – |
| Q4 2017 | $150,000 | -86.5% | 2,781 | -85.5% | 0.00% | -100.0% |
| Q3 2017 | $1,111,000 | +6.2% | 19,150 | -9.6% | 0.00% | 0.0% |
| Q2 2017 | $1,046,000 | +27.9% | 21,190 | +12.4% | 0.00% | 0.0% |
| Q1 2017 | $818,000 | -10.1% | 18,849 | -3.4% | 0.00% | 0.0% |
| Q4 2016 | $910,000 | +2835.5% | 19,514 | +2902.2% | 0.00% | – |
| Q3 2016 | $31,000 | -87.4% | 650 | -85.9% | 0.00% | – |
| Q2 2016 | $247,000 | -3.9% | 4,614 | -19.6% | 0.00% | – |
| Q1 2016 | $257,000 | +27.9% | 5,741 | +9.1% | 0.00% | – |
| Q4 2015 | $201,000 | +64.8% | 5,263 | +37.7% | 0.00% | – |
| Q3 2015 | $122,000 | +0.8% | 3,823 | +4.7% | 0.00% | – |
| Q2 2015 | $121,000 | +16.3% | 3,651 | +45.2% | 0.00% | – |
| Q1 2015 | $104,000 | -20.6% | 2,514 | -21.9% | 0.00% | – |
| Q4 2014 | $131,000 | +14.9% | 3,218 | +2.9% | 0.00% | – |
| Q3 2014 | $114,000 | -25.5% | 3,127 | -5.2% | 0.00% | – |
| Q2 2014 | $153,000 | +31.9% | 3,299 | +17.1% | 0.00% | – |
| Q1 2014 | $116,000 | -12.1% | 2,817 | -18.4% | 0.00% | – |
| Q4 2013 | $132,000 | +175.0% | 3,452 | +70.2% | 0.00% | – |
| Q3 2013 | $48,000 | – | 2,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |